This wiki has undergone a migration to Confluence found Here
20160615 PLA call
Jump to navigation
Jump to search
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
HL7 PLA Call Minutes Location: Phone: +1 770-657-9270, Participant Code: 985371, |
Date: 2016-06-15 Time: 2PM | ||
Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
Attendee | Name
| ||
x | Calvin Beebe | ||
Woody Beeler | |||
Lorraine Constable | |||
Bo Dagnall | |||
Jean Duteau, | |||
Rick Haddorff | |||
x | Tony Julian | ||
Paul Knapp | |||
x | Austin Kreisler, | ||
Lynn Laakso | |||
x | Mary Kay McDaniel | ||
Brian Pech | |||
Wayne Kubick | |||
John Roberts | |||
x | Andy Stechishin | ||
no quorum definition |
Agenda
Agenda review
- Notes of 20160601_PLA_call review
- Action Items
- Mary Kay to mock up M&C for CDA management group
- Mary Kay to talk to Austin re: when we want to actually do the call for input/observations regarding the creation of the CDA management group (Originally planned for Sept WGM)
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
- Mary Kay displays draft mission and charter for CDA mgmt group. Group reviews and makes appropriate edits.
- Discussion over people using DSTU as an endpoint instead of working towards normative
- Discussion over US Realm/affiliate issues
- Discussion over how membership is structured
- For next time (6/29): continue on this M&C document. Mary Kay will not be here.
- Tuesday Q3 could be meeting time in Baltimore during which we do call for input/observations regarding the creation of CDA mgmt group - discuss next time
- Adjourned at 3:08 pm Eastern
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2016 Health Level Seven® International. All rights reserved